• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Life Sciences | News, Analysis, Insights - HIT Consultant

Verily Nabs $700M to Expand Baseline, Verily Health Platforms

by Fred Pennic 12/17/2020 Leave a Comment

Verily Nabs $700M to Expand Baseline, Verily Health Platforms

What You Should Know: - Verily, a subsidiary of Alphabet focused on life sciences and healthcare announced it has raised $700M from current investors, including Alphabet, Silver Lake, Temasek, Ontario Teachers’ Pension Plan and others. - The company plans to use the capital to support rapid expansion of some of Verily’s leading commercial businesses including Baseline, an end-to-end ecosystem designed to make clinical research more efficient; and Verily Health Platforms, which supports
Read More

How Hackers Are Targeting COVID-19 Vaccine Distribution Chains – Q/A

by Fred Pennic 12/16/2020 Leave a Comment

COVID-19 Vaccine Cyber Attacks

With the US and other major countries poised to begin national distribution of multiple FDA-approved COVID-19 vaccines, the cybersecurity threats to secure COVID19 vaccine distribution is imminent. Earlier this month, IBM released a report on malicious cyber actors targeting the COVID-19 cold chain—an integral part of delivering and storing a vaccine at safe temperatures. Impersonating a biomedical company, cyber actors are sending phishing and spear-phishing emails to executives and global
Read More

M&A: Cerner to Acquire Health Division of Kantar for $375M in Cash

by Fred Pennic 12/16/2020 Leave a Comment

M&A: Cerner to Acquire Health Division of Kantar for $375M in Cash

What You Should Know:  - Cerner announces it will acquire Kantar Health, a leading data, analytics, and real-world evidence and commercial research consultancy serving the life science and health care industry. - This acquisition is expected to allow Cerner’s Learning Health Network client consortium and health systems with more opportunities to directly engage with life sciences for funded research studies. The acquisition is expected to close during the first half of
Read More

FDA Authorizes First Fully Over the Counter COVID-19 Home Test

by Fred Pennic 12/16/2020 Leave a Comment

FDA Authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test

What You Should Know: - FDA grants Emergency Use Authorization for Ellume COVID-19 Home Test for non-prescription home use in symptomatic and asymptomatic individuals - The first fully over-the-counter COVID-19 Home Test demonstrated 96% accuracy in a multi-site US clinical study of both adults and children 2 years and above - Ellume is ramping up manufacture, with production on track for over 100,000 tests per day in January 2021 Ellume, a digital diagnostics announced its rapid,
Read More

Abbott Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test

by Fred Pennic 12/15/2020 Leave a Comment

Abbott Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test

What You Should Know: - Abbott Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test that specifically detects levels of IgG antibodies that attach to the virus’ spike protein, which can be helpful to evaluate a person's immune response to vaccines. - Abbott plans to submit its test for the U.S. Food and Drug Administration (FDA) emergency use authorization soon. Abbott, today announced it received CE Mark for its new quantitative SARS-CoV-2 IgG (Immunoglobulin G)
Read More

Backed by Khosla Ventures, Rubedo Life Sciences Secures $12M for Drug Discovery Platform

by Jasmine Pennic 12/04/2020 Leave a Comment

Backed by Khosla Ventures, Rubedo Life Sciences Secures $12M for Drug Discovery Platform

What You Should Know: - Biopharma startup Rubedo Life Sciences raises $12M to develop a broad portfolio of innovative therapies engineered to target cells for chronic age-related diseases. - Rubedo’s proprietary ALEMBIC™ drug discovery platform, has generated a novel pipeline of therapeutic candidates that selectively target senescent cells, pro-inflammatory and pro-fibrotic cell populations that result from a variety of cellular stress and damage. Rubedo Life Sciences, a
Read More

UCB Taps Medisafe to Develop Branded Digital Drug Companions for Antiepileptic Medications

by Fred Pennic 11/24/2020 Leave a Comment

UCB Taps Medisafe to Develop Branded Digital Drug Companions for Antiepileptic Medications

What You Should Know: - UCB has selected Medisafe to develop branded digital drug companions for antiepileptic medications, marking the company’s official entry into the digital therapeutics space. - The initial collaboration will primarily be focused on their antiepileptic medications, but they are exploring its use for additional brands.  Medisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital
Read More

GE Healthcare Acquires Swedish Photon Counting CT Startup Prismatic Sensors AB

by Fred Pennic 11/20/2020 Leave a Comment

GE Healthcare Acquires Swedish Photon Counting CT Startup Sensors AB

What You Should Know: - GE Healthcare acquires Swedish startup Sensors AB, specializing in photon counting detectors for an undisclosed amount. - The acquisition underscores the company’s continued investment and dedication in photon-counting CT technology (PCCT) - PCCT is anticipated to further expand the clinical capabilities of traditional CT technology GE Healthcare today announced its acquisition of Prismatic Sensors AB, a Swedish-based startup specializing in photon
Read More

7 Best Practices for Third-Party Risk Management in the Pharmaceutical Industry

by Dr. Aleksandr Yampolskiy, CEO of SecurityScorecard 11/19/2020 Leave a Comment

7 Best Practices for Third-Party Risk Management in the Pharmaceutical Industry

The globalization of the pharmaceutical industry has forced pharma companies to outsource, increasing their reliance on third-party vendors and suppliers. As this supply chain grows in complexity, companies find themselves grappling with a growing amount of cyber risk.  A data breach in the pharmaceutical industry can cost companies upwards of $5 million and costs can rise significantly if a third-party vendor or supplier is the cause of a data breach. For this reason, organizations must
Read More

FDA Authorizes First At-Home COVID-19 Test, Results in 30 Mins or Less

by Fred Pennic 11/18/2020 Leave a Comment

FDA Authorizes First At-Home Molecular COVID-19 Test

What You Should Know: - FDA approves emergency use authorization (EUA) for Lucira Health’s all-in-one-test kit for COVID-19 self-testing at home. - The streamlined Lucira COVID-19 All-In-One Test Kit, which fits in the palm of a hand, extracts genetic material from the virus and amplifies it. This process takes up to 30 minutes, but a positive test result can be generated in as few as 11 minutes. On late Tuesday, the Food and Drug Administration (FDA) issued an emergency use
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 76
  • Go to page 77
  • Go to page 78
  • Go to page 79
  • Go to page 80
  • Interim pages omitted …
  • Go to page 90
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |